LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Q32 Bio Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERQTTB
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / QTTB COVERAGE

What’s moving Q32 Bio Inc. now

Current reporting with the operating signal separated from the noise.

01
Stock Titan

Q32 Bio Inc. (QTTB) investors disclose 5.49% stake in Schedule 13G/A

The story matters when it changes Q32 Bio Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
TradingView

Q32 Bio Inc expected to post a loss of 54 cents a share - Earnings Preview

Investors are testing whether Q32 Bio Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
TradingKey

QTTB|Q32 Bio Inc|Price:15.700|Chg%:+0.020

The story matters when it changes Q32 Bio Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
TradingKey

Q32 Bio Inc (QTTB) Valuation: PE, PB & Fair Value Analysis

The development tests whether Q32 Bio Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
05
TradingKey

Q32 Bio Inc (QTTB) Risk Assessment: Volatility, Financial Risk & Investment Risk

The story matters when it changes Q32 Bio Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
06
Stock Titan

Q32 Bio Inc. SEC Filing (Jul 29, 2026)

The story matters when it changes Q32 Bio Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
07
Kalkine Media

Q32 Bio Inc. Files Registration for 6.875 Million Shares Resale by Private Placement Investors

Investors are testing whether Q32 Bio Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
08
TradingKey

Q32 Bio Inc (QTTB) Financial Health: Profitability & Balance Sheet Analysis

Investors are testing whether Q32 Bio Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest QTTB filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-05 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-13 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-10 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-15 · Period 2026-07-14SEC ↗8-KMaterial company eventFiled 2026-07-13 · Period 2026-07-13SEC ↗8-KMaterial company eventFiled 2026-07-13 · Period 2026-07-13SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-30 · Period 2026-06-12SEC ↗SCHEDULE 13G/AOfficial SEC filingFiled 2026-07-31SEC ↗
EARNINGS / QUARTERLY TRACKER

Q32 Bio Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.